Mild cognitive impairment: Stability and predictability of neuropsychological test performance over time by de Jager, C, Budge, M

Stability and predictability of the classification of mild cognitive impairment as assessed by episodic memory test performance over time. by de Jager, C, Budge, M

Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests. by de Jager, C, Milwain, E, Budge, M

Utility of TICS-M for the assessment of cognitive function in older adults. by de Jager, C, Budge, M, Clarke, R

Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE. by de Jager, C, Schrijnemaekers, A, Honey, T, Budge, M

Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. by Nagy, Z, Combrinck, M, Budge, M, Mcshane, R

Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. by De Jager, C, Hogervorst, E, Combrinck, M, Budge, M

Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls. by Schrijnemaekers, A, de Jager, C, Hogervorst, E, Budge, M

Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. by Budge, M, De Jager, C, Hogervorst, E, Smith, A

Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. by Hogervorst, E, De Jager, C, Budge, M, Smith, A

Predicting cognitive decline in healthy older adults. by De Jager, C, Blackwell, A, Budge, M, Sahakian, B

NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant by Johnson, N, Bell, P, Jonovska, V, Budge, M, Sim, E

Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. by Dixon, R, Bradley, K, Budge, M, Styles, P, Smith, A

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease by Hogervorst, E, Ribeiro, H, Molyneux, A, Budge, M, Smith, A

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. by Hogervorst, E, Ribeiro, H, Molyneux, A, Budge, M, Smith, A

Serum total testosterone is lower in men with Alzheimer's disease. by Hogervorst, E, Williams, J, Budge, M, Barnetson, L, Combrinck, M, Smith, A

The associations of age, cardiovascular morbidity, and plasma homocysteine with brain atrophy in stroke-free, nondemented older adults. by Budge, M, Bradley, K, Chen, J, Smith, S, de Jager, C, Smith, D

Longitudinal MRI brain volume changes in non-demented 60-90-year-olds: The associations of age, gender and memory performance by Budge, M, Bradley, K, Smith, S, De Jager, C, Smith, A, Chen, J

Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. by Bradley, K, Bydder, G, Budge, M, Hajnal, J, White, S, Ripley, B, Smith, A

Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease by Bradley, K, Bydder, G, Budge, M, Hajnal, J, White, S, Ripley, B, Smith, A